SAMTREX

This brand name is authorized in Nigeria.

Active ingredients

The drug SAMTREX contains one active pharmaceutical ingredient (API):

1
UNII DL9055K809 - LEVAMISOLE HYDROCHLORIDE
 
Read more about Levamisole

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
04-2016 Tablet Samtrex Tablet TAB 40 mg 912 Levamisole 04-2016 Samtrex Tablet Levamisole Maize Starch D.C.P, Gelatine, Starch For Paste, Purified Talc, Magnesium Stearate Methyl Paraben Propyl Paraben Anthelmintics Oral 47.2 mg, 76 mg, 40 mg, 2 mg, 4 mg, 2 mg, 1.6 mg, 0.36 mg, 0.08 mg Tablet Over The Counter (Otc) Sam Pharmaceutical Limited Sam Pharmaceutical Ltd. Nigeria 2021-09-28 2026-09-27 28/09/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P02CE01 Levamisole P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CE Imidazothiazole derivatives
Discover more medicines within P02CE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database 04-2016

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈